Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11535615 Heterocyclic compounds as immunomodulators

Patent 11535615 was granted and assigned to Incyte on December, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Liangxing Wu0

Wenqing Yao0

Neil Lajkiewicz0

Date of Patent

December 27, 2022

0

Patent Application Number

170186530

Date Filed

September 11, 2020

0

Patent Citations

US Patent 10793505 Unit and process for purification of crude methyl methacrylate

US Patent 10793565 Heterocyclic compounds as immunomodulators

US Patent 10800768 Heterocyclic compounds as immunomodulators

0

US Patent 10806785 Immunomodulator compounds and methods of use

0

US Patent 10906920 Heterocyclic compounds as immunomodulators

US Patent 11124511 Heterocyclic compounds as immunomodulators

US Patent 11339149 Heterocyclic compounds as immunomodulators

US Patent 11401279 Pyrido[3,2-d]pyrimidine compounds as immunomodulators

...

Patent Citations Received

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

0

Patent Primary Examiner

D Margaret M Seaman

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11535615 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool